Click for best price
Noninvasive Cancer Diagnostics Technology Market Size, Share 2022
Noninvasive Cancer Diagnostics Technology is a process for the detection of disease through minimal incisions into the body. Noninvasive cancer diagnostic technologies provide fast and convenient procedures for noninvasive early detection of cancer and provide a valuable aid to the clinician and increased comfort to the patient.Noninvasive Cancer Diagnosis Technologies are used to identify breast, lung, blood, and other cancers.
This report contains market size and forecasts of Noninvasive Cancer Diagnostics Technology in Global, including the following market information:
Global Noninvasive Cancer Diagnostics Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Noninvasive Cancer Diagnostics Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunoassays Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Noninvasive Cancer Diagnostics Technology include Precision Therapeutics, Affymetrix Inc., Gen-Probe Incorporated, AVIVA Biosciences Corporation, A&G Pharmaceutical, BIOVIEW Inc., Quest Diagnostics Incorporated, Digene Corporation and Laboratory Corporation of America Holdings.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Noninvasive Cancer Diagnostics Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Noninvasive Cancer Diagnostics Technology Market, by Technology, 2017-2022, 2023-2028 ($ millions)
Global Noninvasive Cancer Diagnostics Technology Market Segment Percentages, by Technology, 2021 (%)
Immunoassays
Molecular Diagnostics
Clinical Chemistry
Others
Global Noninvasive Cancer Diagnostics Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Noninvasive Cancer Diagnostics Technology Market Segment Percentages, by Application, 2021 (%)
Medical Device Manufacturing Company
Oncology Laboratories
Government and Private Research Institutions
Academic Institutions and Pharmaceutical Companies
Others
Global Noninvasive Cancer Diagnostics Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Noninvasive Cancer Diagnostics Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Noninvasive Cancer Diagnostics Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Noninvasive Cancer Diagnostics Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Precision Therapeutics
Affymetrix Inc.
Gen-Probe Incorporated
AVIVA Biosciences Corporation
A&G Pharmaceutical
BIOVIEW Inc.
Quest Diagnostics Incorporated
Digene Corporation
Laboratory Corporation of America Holdings.
| Report Attributes |
Report Details |
| Report Title |
Noninvasive Cancer Diagnostics Technology Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Noninvasive Cancer Diagnostics Technology Market Definition
1.2 Market Segments
1.2.1 Market by Technology
1.2.2 Market by Application
1.3 Global Noninvasive Cancer Diagnostics Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Noninvasive Cancer Diagnostics Technology Overall Market Size
2.1 Global Noninvasive Cancer Diagnostics Technology Market Size: 2021 VS 2028
2.2 Global Noninvasive Cancer Diagnostics Technology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Noninvasive Cancer Diagnostics Technology Players in Global Market
3.2 Top Global Noninvasive Cancer Diagnostics Technology Companies Ranked by Revenue
3.3 Global Noninvasive Cancer Diagnostics Technology Revenue by Companies
3.4 Top 3 and Top 5 Noninvasive Cancer Diagnostics Technology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Noninvasive Cancer Diagnostics Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Noninvasive Cancer Diagnostics Technology Players in Global Market
3.6.1 List of Global Tier 1 Noninvasive Cancer Diagnostics Technology Companies
3.6.2 List of Global Tier 2 and Tier 3 Noninvasive Cancer Diagnostics Technology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Technology - Global Noninvasive Cancer Diagnostics Technology Market Size Markets, 2021 & 2028
4.1.2 Immunoassays
4.1.3 Molecular Diagnostics
4.1.4 Clinical Chemistry
4.1.5 Others
4.2 By Technology - Global Noninvasive Cancer Diagnostics Technology Revenue & Forecasts
4.2.1 By Technology - Global Noninvasive Cancer Diagnostics Technology Revenue, 2017-2022
4.2.2 By Technology - Global Noninvasive Cancer Diagnostics Technology Revenue, 2023-2028
4.2.3 By Technology - Global Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Noninvasive Cancer Diagnostics Technology Market Size, 2021 & 2028
5.1.2 Medical Device Manufacturing Company
5.1.3 Oncology Laboratories
5.1.4 Government and Private Research Institutions
5.1.5 Academic Institutions and Pharmaceutical Companies
5.1.6 Others
5.2 By Application - Global Noninvasive Cancer Diagnostics Technology Revenue & Forecasts
5.2.1 By Application - Global Noninvasive Cancer Diagnostics Technology Revenue, 2017-2022
5.2.2 By Application - Global Noninvasive Cancer Diagnostics Technology Revenue, 2023-2028
5.2.3 By Application - Global Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Noninvasive Cancer Diagnostics Technology Market Size, 2021 & 2028
6.2 By Region - Global Noninvasive Cancer Diagnostics Technology Revenue & Forecasts
6.2.1 By Region - Global Noninvasive Cancer Diagnostics Technology Revenue, 2017-2022
6.2.2 By Region - Global Noninvasive Cancer Diagnostics Technology Revenue, 2023-2028
6.2.3 By Region - Global Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Noninvasive Cancer Diagnostics Technology Revenue, 2017-2028
6.3.2 US Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.3.3 Canada Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.3.4 Mexico Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Noninvasive Cancer Diagnostics Technology Revenue, 2017-2028
6.4.2 Germany Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.4.3 France Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.4.4 U.K. Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.4.5 Italy Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.4.6 Russia Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.4.7 Nordic Countries Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.4.8 Benelux Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Noninvasive Cancer Diagnostics Technology Revenue, 2017-2028
6.5.2 China Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.5.3 Japan Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.5.4 South Korea Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.5.5 Southeast Asia Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.5.6 India Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Noninvasive Cancer Diagnostics Technology Revenue, 2017-2028
6.6.2 Brazil Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.6.3 Argentina Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Noninvasive Cancer Diagnostics Technology Revenue, 2017-2028
6.7.2 Turkey Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.7.3 Israel Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.7.4 Saudi Arabia Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
6.7.5 UAE Noninvasive Cancer Diagnostics Technology Market Size, 2017-2028
7 Players Profiles
7.1 Precision Therapeutics
7.1.1 Precision Therapeutics Corporate Summary
7.1.2 Precision Therapeutics Business Overview
7.1.3 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.1.4 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.1.5 Precision Therapeutics Key News
7.2 Affymetrix Inc.
7.2.1 Affymetrix Inc. Corporate Summary
7.2.2 Affymetrix Inc. Business Overview
7.2.3 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.2.4 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.2.5 Affymetrix Inc. Key News
7.3 Gen-Probe Incorporated
7.3.1 Gen-Probe Incorporated Corporate Summary
7.3.2 Gen-Probe Incorporated Business Overview
7.3.3 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.3.4 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.3.5 Gen-Probe Incorporated Key News
7.4 AVIVA Biosciences Corporation
7.4.1 AVIVA Biosciences Corporation Corporate Summary
7.4.2 AVIVA Biosciences Corporation Business Overview
7.4.3 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.4.4 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.4.5 AVIVA Biosciences Corporation Key News
7.5 A&G Pharmaceutical
7.5.1 A&G Pharmaceutical Corporate Summary
7.5.2 A&G Pharmaceutical Business Overview
7.5.3 A&G Pharmaceutical Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.5.4 A&G Pharmaceutical Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.5.5 A&G Pharmaceutical Key News
7.6 BIOVIEW Inc.
7.6.1 BIOVIEW Inc. Corporate Summary
7.6.2 BIOVIEW Inc. Business Overview
7.6.3 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.6.4 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.6.5 BIOVIEW Inc. Key News
7.7 Quest Diagnostics Incorporated
7.7.1 Quest Diagnostics Incorporated Corporate Summary
7.7.2 Quest Diagnostics Incorporated Business Overview
7.7.3 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.7.4 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.7.5 Quest Diagnostics Incorporated Key News
7.8 Digene Corporation
7.8.1 Digene Corporation Corporate Summary
7.8.2 Digene Corporation Business Overview
7.8.3 Digene Corporation Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.8.4 Digene Corporation Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.8.5 Digene Corporation Key News
7.9 Laboratory Corporation of America Holdings.
7.9.1 Laboratory Corporation of America Holdings. Corporate Summary
7.9.2 Laboratory Corporation of America Holdings. Business Overview
7.9.3 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Major Product Offerings
7.9.4 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Revenue in Global Market (2017-2022)
7.9.5 Laboratory Corporation of America Holdings. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Noninvasive Cancer Diagnostics Technology Market Opportunities & Trends in Global Market
Table 2. Noninvasive Cancer Diagnostics Technology Market Drivers in Global Market
Table 3. Noninvasive Cancer Diagnostics Technology Market Restraints in Global Market
Table 4. Key Players of Noninvasive Cancer Diagnostics Technology in Global Market
Table 5. Top Noninvasive Cancer Diagnostics Technology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Noninvasive Cancer Diagnostics Technology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Noninvasive Cancer Diagnostics Technology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Noninvasive Cancer Diagnostics Technology Product Type
Table 9. List of Global Tier 1 Noninvasive Cancer Diagnostics Technology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Noninvasive Cancer Diagnostics Technology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Technology ? Global Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Technology - Noninvasive Cancer Diagnostics Technology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Technology - Noninvasive Cancer Diagnostics Technology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Noninvasive Cancer Diagnostics Technology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Noninvasive Cancer Diagnostics Technology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2023-2028
Table 30. Precision Therapeutics Corporate Summary
Table 31. Precision Therapeutics Noninvasive Cancer Diagnostics Technology Product Offerings
Table 32. Precision Therapeutics Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 33. Affymetrix Inc. Corporate Summary
Table 34. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Product Offerings
Table 35. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 36. Gen-Probe Incorporated Corporate Summary
Table 37. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Product Offerings
Table 38. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 39. AVIVA Biosciences Corporation Corporate Summary
Table 40. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Product Offerings
Table 41. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 42. A&G Pharmaceutical Corporate Summary
Table 43. A&G Pharmaceutical Noninvasive Cancer Diagnostics Technology Product Offerings
Table 44. A&G Pharmaceutical Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 45. BIOVIEW Inc. Corporate Summary
Table 46. BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Product Offerings
Table 47. BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 48. Quest Diagnostics Incorporated Corporate Summary
Table 49. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Product Offerings
Table 50. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 51. Digene Corporation Corporate Summary
Table 52. Digene Corporation Noninvasive Cancer Diagnostics Technology Product Offerings
Table 53. Digene Corporation Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
Table 54. Laboratory Corporation of America Holdings. Corporate Summary
Table 55. Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Product Offerings
Table 56. Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Noninvasive Cancer Diagnostics Technology Segment by Technology in 2021
Figure 2. Noninvasive Cancer Diagnostics Technology Segment by Application in 2021
Figure 3. Global Noninvasive Cancer Diagnostics Technology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Noninvasive Cancer Diagnostics Technology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Noninvasive Cancer Diagnostics Technology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Noninvasive Cancer Diagnostics Technology Revenue in 2021
Figure 8. By Technology - Global Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 12. US Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 16. Germany Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 17. France Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 24. China Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 28. India Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 30. Brazil Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Noninvasive Cancer Diagnostics Technology Revenue Market Share, 2017-2028
Figure 33. Turkey Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Noninvasive Cancer Diagnostics Technology Revenue, (US$, Mn), 2017-2028
Figure 37. Precision Therapeutics Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. A&G Pharmaceutical Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Digene Corporation Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
